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Abstract— In clinical oncology, Positron Emission 
Tomography (PET) imaging can be used to assess therapeutic 
response by quantifying the evolution of semi-quantitative values 
such as SUV, early during treatment or after treatment. Current 
guidelines do not include metabolically active tumor volume 
(MATV) measurements and derived parameters such as total 
lesion glycolysis (TLG) to characterize the response to the 
treatment. To achieve automatic MATV variation estimation 
during treatment, we propose an approach based on the change 
detection principle using the recent paradoxical theory, which 
models imprecision, uncertainty and conflict between sources. It 
was applied here simultaneously to pre and after treatment PET 
scans. The proposed method was applied to both simulated and 
clinical datasets, and its performance was compared to adaptive 
thresholding applied separately on pre and post treatment PET 
scans. On simulated datasets, the adaptive threshold was 
associated with significantly higher classification errors than the 
developed approach. On clinical datasets, the proposed method 
led to results more consistent with the known partial responder 
status of these patients. The method requires accurate rigid 
registration of both scans which can be obtained only in specific 
body regions and does not explicitly model uptake heterogeneity. 
In further investigations the change detection of intra-MATV 
tracer uptake heterogeneity will be developed by incorporating 
textural features into the proposed approach. 
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I. INTRODUCTION 
N clinical oncology, Positron Emission Tomography (PET) 
imaging is increasingly used for diagnosis [1], patient 
monitoring studies [2] and the estimation of the 
metabolically active tumor volume (MATV) for radiotherapy 
planning purposes [3]. Within the context of patient follow-up 
and therapy assessment, the tumor metabolic changes induced 
by chemotherapy and/or radiotherapy may arise prior to 
anatomic changes characterized using morphological imaging 
such as computed tomography (CT) or magnetic resonance 
imaging (MRI) [4]. The response to therapy may be assessed 
by comparing sequential PET scans acquired before 
("baseline"), during ("early assessment") and after ("late 
assessment") treatment [5-7]. Both qualitative and quantitative 
approaches have been proposed [8]. Qualitative methods have 
been considered significantly less accurate and reproducible 
than quantitative approaches for several applications [9] [10]. 
Quantification in PET may be carried out either on dynamic or 
static acquisitions, with similar reproducibility [11]. Requiring 
longer acquisitions and arterial sampling, the approaches 
based on dynamic PET imaging are currently not extensively 
used in clinical practice. The standardized uptake value (SUV) 
computed on static PET scans is still the most widely used 
semi-quantitative index in oncology clinical practice. Two 
indexes, namely the maximum SUV (SUVmax) and the mean 
SUV (SUVmean) within a previously defined region of interest 
(ROI) are currently used in routine for the quantification and 
will be included in the present study. The reproducibility of 
both parameters has been assessed in different studies [12, 13], 
and compared to the reproducibility of MATV measurements 
with various automated and semi-automated methodologies 
[14]. In order to better characterize MATV, others indexes 
such as the total lesion glycolysis (TLG) were defined as the 
product of the MATV and the associated mean SUV [15]. 
In order to standardize therapy response assessment in 
oncology, recommendations such as WHO [16] and RECIST 
[17] have been established and are based on measurements of 
anatomic tumor dimensions on CT scans. More recently, it has 
been suggested in PERCIST [18] to characterize the response 
according to the metabolic activity quantified with PET 
imaging using SUV. Based on the reproducibility of such 
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indices as previously investigated [12-14], confidence 
intervals were derived in order to characterize response, partial 
response, absence of response and progressive disease [18]. 
Due to the lack of appropriate automated tools, response 
assessment in clinical practice is usually carried out using 
simple SUV measurements and do not consider the overall or 
intra MATV variations. 
All the approaches mentioned above are based on the use of 
global parameters such as SUV or MATV. By contrast with 
these “global” methods, few approaches have been developed 
to consider a voxel by voxel analysis. A method comparing 
the variation of the apparent diffusion coefficient (ADC) of 
each tumor voxel between the pre-treatment and mid-
treatment scans has been proposed for functional MRI 
imaging (fMRI) [19]. Measuring the cellular density, the ADC 
variation of a tumor voxel can be associated with therapy 
response. The ADC variation measurements led to the creation 
of a functional diffusion map (fDM), in which each tumor 
voxel was classified as responder, stable or progressive. 
Another recent method proposed assessing the response by 
comparing two follow-up PET images previously co-registred 
using associated CT datasets [20]. A biparametric map was 
generated and analyzed in order to identify the tracer uptake 
variations within the tumor volumes. 
The aim of this study was to present a novel method to 
characterize MATV response to therapy, based on the change 
detection principle previously proposed within the context of 
satellite and sonar imaging [21] [22]. In the proposed 
approach, the MATV are first delineated in each PET scan 
individually using a robust automatic algorithm [23]. 
Subsequently, signatures characterizing changes between the 
scans are defined by two parameters, one global and one local. 
The change detection process is based on the recent Dezert-
Smarandache (DSm) theory, combining uncertain and 
paradoxical information [24]. By modeling uncertainty, 
imprecision and conflicting data between sources, such a 
process using the paradoxical theory may add valuable 
information to characterize the tumor evolution than the 
simple difference of binary segmented maps obtained on each 
image independently. The local voxel by voxel therapy 
response is finally deduced from the original follow-up PET 
images and the change detection map. In addition to the 
overall volume and activity evolution between two or more 
PET scans, the goal of the proposed method was to provide a 
quantitative accurate voxel-by-voxel response map using color 
coding. 
The proposed method was applied on simulated and clinical 
follow-up 18F-FDG PET scans of patients with esophageal 
cancer treated by radio-chemotherapy. The change detection 
approach was compared with the current quantitative methods 
used in patient monitoring (SUV variations) and MATV 
threshold-based delineation applied independently to each of 





Fig 1: Flowchart of the proposed approach. In the image mapping step, black voxels are those classified as belonging to the MATV by the FLAB algorithm. The 
remaining voxels are classified as belonging to the background. In the mass function assignment definition, for all images, the voxels intensities represent values 
between 0 and 1. The maximum of credibility generates a binary ‘change map’ (white voxels ‘change’, black voxels ‘no change’). In the classification step, using 
this ‘change map’ in combination with SUV differences between pre and post treatment as well as the mean measurements of both pre and post treatment scans, 
the fusion map is deduced in which green voxels are stable (‘change’ with less than 30% evolution or ‘no change’ classified as tumors depending on mean 
measurements), blue voxels are responding (‘change’ with more than 30% reduction), red voxels are progressive (‘change with more than 30% increase), and the 





II. MATERIALS AND METHODS 
Figure 1 presents a flowchart of the proposed method, each 
step being detailed in the following sections. In the following, 
the term noise denotes the statistical variations of voxels 
values due to the signal acquisition and image reconstruction 
processes, whereas the term heterogeneity denotes variations 
of uptake in small or larger groups of voxels within the 
MATV that may be characterized as spatial patterns associated 
with subjacent biological processes such as hypoxia or 
vascularization [25]. 
A. Pre processing 
1)  Local-based analysis 
 
Our method is aimed at characterizing local evolutions of 
volumes of interest at a voxel level in follow-up PET imaging. 
In this work, we therefore assume that the lesions of interest 
can be first isolated by a clinician in a 3D bounding box, 
which is determined on co-registered PET scans (figure 2). 
This bounding box should be large enough to encompass the 
entire tumor volume on all considered scans. Its shape, not 
necessarily cubic, should allow in most cases excluding 
physiological uptake close to the tumor which may disturb the 
change detection process, although depending on the type of 
malignancy, extent and location of the lesions, the process 




Fig. 2: Illustration of a VOI definition in the pre-treatment scan (a) and 
automatically reported on the registered mid-treatment scan (b). 
 
 
2)  Image deconvolution 
 
Tumor volumes observed in PET images are affected by the 
partial volume effects (PVE), due to the limited spatial 
resolution of PET scanners, which is about 4-6 mm full width 
at half maximum (FWHM) in state-of-the art PET/CT 
scanners [26]. The PVE lead to activity cross contamination 
between adjacent structures characterized by different uptake 
levels and might significantly impact measured activity in 
structures with sizes below three times the FWHM. In the co-
registered PET scans, voxels most affected by PVE (mostly on 
the borders between structures of interest) may not have the 
same spatial coordinates, which can further disturb the change 
detection method. Moreover, the PVE affect the absolute SUV 
values extracted from each scan. These measurements may be 
significantly biased and this would lead to significant under or 
over estimation of the tracer uptake variation between the 
follow-up PET scans. Consequently, a PVE correction (PVC) 
was applied to each follow-up scan. The chosen PVC 
approach is based on 3D voxel-wise correction using an 
iterative deconvolution improved by wavelet and curvelet-
based optimal denoising [27] [28]. This pre-processing step 
allows reducing the size of the blurred frontiers and extracting 
corrected SUVs for the quantitative characterization of the 
evolution of the tracer uptake. 
 
3)  PET/PET registration 
 
As mentioned above, the follow-up PET scans are assumed 
to be registered at a voxel level before the change detection 
method can be applied. Within the context of patient 
monitoring studies, the PET/CT images may be acquired at 
several weeks interval. In our study, the PET/PET registration 
was carried out according to a previously published approach 
[29]. PET scans were first registered with their corresponding 
CT acquired in the same bed position. Then, having more 
landmarks than the functional images, the two CT scans were 
registered with the MIPAV software using a rigid 
transformation, by optimizing the least square criterion. 
Finally, the computed CT/CT transformation matrix was 
applied to the PET scans leading to their registration at the 
voxel level. A rigid registration was used in our study for two 
reasons. First, the analysis was carried out on small 3D 
volumes of interest centered in the mediastinum. Second, 
elastic registration would deform the tumor shapes and 
volumes when registering one to the other, which would bias 
the comparison analysis on the voxel level of the MATV 
evolution between the two scans. This approach however 
limits the applicability of the method to body regions less 
impacted by respiratory motion and registration issues such as 
patient morphological changes between the two scans. 
In addition, the local change signature of each voxel was 
performed within a sliding cube of 3×3×3 voxels centered on 
the voxel of interest, which is expected to reduce the impact of 
small (one or two voxels maximum) registration errors (see 
end of section II.B.2). 
B. Change Detection method 
This approach is based upon change detection principle 
using the DSm theory to model the evolution of the tumor. 
The change detection has been widely used for satellite 
imaging [21] [22] within the context of environmental (forest, 
agriculture) monitoring or in urban studies. However, the 
change detection method has not been applied to PET imaging 
up to now. The proposed approach was adapted from a method 
applied to SAR (Synthetic Aperture Imaging) images used for 
the detection of abrupt changes due to natural environmental 
damages [30]. 
 
1) Image Mapping 
 
Let us consider  and , two 3D PET volumes of follow-
up scans acquired respectively before and during (or after) 
treatment. Both images are assumed to be co-registered as 




delineating the MATV in each image in order to obtain a first 
estimate of the tumor volumes that will be subsequently 
compared in the change detection approach. The algorithm 
used in this step (Fuzzy Local Adaptive Bayesian, FLAB) has 
been previously validated [23]. Using a fuzzy Bayesian model, 
the approach is based on a local adaptive prior model and an 
observation model assumed to be a mixture of Gaussian 
distributions. The parameters of the mixture are estimated with 
the stochastic expectation maximization (SEM) algorithm 
[31]. The voxels classification into tumor or background class 
is carried out according to the maximum likelihood criterion, 
based on the posterior probability. Illustrated in figure 1, black 
voxels are those classified as belonging to the class ‘MATV’ 
by the FLAB algorithm, whereas the other voxels have been 
classified as ‘background’. This step provides some 
parameters that are subsequently used in the change signature 
(see sections II.B.2):  
The Gaussian distributions, noted  , are defined by their 
mean and variance (	 	, ), where  denotes the MATV ( = ) or background ( = ) and  denotes the 
affiliation to image 1 or 2. 
2) Change signature 
 
The second step of the process consists in characterizing the 
change between the two maps obtained at the previous step 
(section II.B.1), considering two levels of observation: one 
global and one local. 
The global evolution was characterized using a measure of 
distance between the distributions. The Bhattacharyya 
criterion () [32] was used to measure the overlap between 
two probability distributions  and :  
(, ) = ()() 					(1) 
A global change criterion (, ) can be deduced from the : (, ) = 1 − ()() 							(2) 
On the one hand, for differentiated distributions,  tends to 
0 and  tends to 1. On the other hand, when  and  are 
similar,  tends to 1 and  tends to 0. In the proposed 
method, four distances were computed by considering for  
and , the distributions  associated with the PET follow-up 
images  and . For example, the distance between the 
MATV distribution in the pre-treatment scan  !"#  and the 
distribution corresponding to the BD in the post-treatment 
scan $%  was defined as: 
( !"# , $% ) = 1 − & !"# ()$% () 							(3) 
The local evolution was designed based on a contrast 
measurement between the two images. At the local level, a 
given voxel is characterized by its value and the probability 
density function of the class it belongs to, as identified in the 
mapping step. For each voxel, the membership of the class 
would differ when the probability density function (pdf) of its 
class has changed, although its value could be similar in both 
images. The membership would also differ if the voxel 
belongs to a class with similar pdf while its value has changed 
significantly. The membership change of a voxel ( between 
the image  and  was therefore defined as a contrast 
measurement between the two pdfs  and : 
(),*)(() = 1 − +, -((())((())	, ((())((()).						(4) 
where i(t) is the intensity of the voxel t in the image. The 
contrast associated to the MATV class is estimated for the 
voxel ( with the distributions  !"#  and  !"#  associated with 
the pre and post-treatment scans: 
0123456 ,123457 8(() = 1 − +, - !"# ((()) !"# ((()) ,  !"#
 ((()) !"# ((()).	(5) 
This measure allows characterizing the evolution of the 
classes’ pdf and the voxel variation within its class and 
assumes that the follow-up images are registered voxel by 
voxel. In order to reduce the impact of potential 
misregistration, the contrast for each voxel ( was computed 
within a 3×3×3 cube centered on the voxel ( by averaging the 
values of the 27 voxels in the cube and assigning the resulting 
value to the center voxel. 
3)  Change detection with paradoxical theory 
 
In our method, the change detection process is carried out 
using the Dezert-Smarandache (DSm) theory of plausible and 
paradoxical reasoning [24]. The DSm theory is a 
generalization of the classical Dempster-Shafer (DS) theory. 
Modeling data using basic belief functions, the DSm theory 
allows combining different types of information sources and 
dealing with their inherent imprecision and uncertainties, with 
a better management of conflicting sources than the DS 
theory. 
Within the context of change detection, the goal is not to 
achieve fusion of information provided by the different 
sources, but rather to directly model these changes using 
specific basic belief functions. In DS and DSm theories a 
“frame of discernment” defining the hypotheses has to be 
defined. Usually in change detection, the two elementary 
hypotheses are “change” and “no-change” with a frame of 
discernment defined as Θ = {;<= , ;>?	<=} [33]. The “hyper-
power set” DΘ is derived from the frame of discernment Θ and 
contains single and composite hypotheses as follows: 
DΘ = {∅	, ;<= , ;>?	<=	, ;<= ∪ ;>?	<= 	, ;<= ∩ ;>?	<=}							(6)	 
In DSm theory, data are modeled using basic belief 
functions + defined in DΘ and verifying: 
+ ∶ 	DΘ → H0,1J 		K +(∅) = 0L +()
!∈%Θ
= 1										(7) 
where  is a proposition, either single or composite of Θ. By 
analogy with the DS theory, the traditional belief functions of 
credibility and plausibility characterizing proposition A can be 




PQ() = L +()$⊆S$∈%T
														UV() = L +()!∩$W∅$∈%T
								(8) 
In order to apply the DSm theory within the context of 
change detection using the global and local change signature, 
the basic belief assignments were defined as provided in table 
1 with the distance (, ) (eq. 3) and the contrast between 
membership change (, ) (eq. 4) where  and  are the 
probability density functions  (() associated with images  
and  is the class assigned to voxel ( after the mapping step 
(section II.B.1). 
A tumor evolution, modeled by the basic belief assignment +(;<=), can be characterized by a high contrast between 
membership change and a significant distance between the 
pdfs. On the contrary, small values of contrast and distance 
between pdfs describe stable uptakes between the two scans 
and are modeled by the basic belief assignment +(;>?	<=). 
The two others basic belief assignments corresponding to the 
union and the intersection of ;<= and ;>?	<= characterize 
respectively the uncertain and the conflict. They are defined 
with respect to the belief mass function definition in (eq. 7). 
Figure 3 illustrates the pdfs corresponding to the tumor and 
background classes in the pre and post-treatment images. Each 
term in table 1 can be described and explained by a specific 
arrangement of the pdfs. The notions of uncertainty and 
paradox are stressed in the definition of +(;<= ∪ ;>?	<=) and +(;<= ∩ ;>?	<=), respectively. 
TABLE I 
Hypothesis Mass 
∅ 0 ;<= (, ) × 	(, ) ;>?	<= 01 − (, )8 ×	01 − (, )8 ;<= ∪ ;>?	<= 01 − (, )8 × 	(, ) ;<= ∩ ;>?	<= (, ) ×	01 − (, )8 
Definition of the mass function assignment with the distance (, ) and 
the contrast between membership change (, ) where  and  are the 
probability density function (() associated to images  and  is the class 
affected to voxel (. 
As illustrated in figure 1, in the map corresponding to the 
basic belief assignments of the intersection, voxels different 
between the pre and post-treatment scans are emphasized, 
which illustrates the conflict between the sources. By contrast, 
voxels similar in both scans are emphasized in the map 
corresponding to the basic belief assignments of the union, 
representing the uncertainty between the sources. 
After the computation of the basic belief functions, a 
‘change map’ (see figure 1) can be created through the 
maximum of credibility between the elementary hypotheses 
according to the credibility function defined in (eq. 8). This 
‘change map’ provides a description of the evolution between 
the PET follow-up scans  and  by classifying the voxels as 
“change” or “no-change”. According to (eq.8), the plausibility 
associated to the elementary hypotheses ;<= and ;>?	<= are 
always equal to 1. Therefore, the maximum of plausibility 
criterion was not used in our approach. The basic belief 
assignments of table 1 were defined in the general case in 
which several sources of information can be considered. In 
this paper, the change detection approach has been applied in 
the particular case where only one source of information is 
considered: the mean value in a cube of 333 voxels. In 
that case, the maximum of credibility criterion compares (, ) and H1 − 	(, )J: if (, )>[1- (, )], then the 





Fig. 3: The pdf of both classes, before treatment (image 1) and after treatment 
(image 2), is represented along the y-axis, as a function of voxel intensity 
(along the x-axis). In each figure, the intensity of one voxel (t) is represented, 
before and after treatment, by a black circle. The pdf of the class assigned to 
voxel t is represented by the bold line. 
 
(a) (‘no ch’). Voxel t was assigned to the same class before and after treatment 
(D(p,q) is low) and the membership degree did not change much (C(p,q) is 
low): the confidence that the voxel did not change is high. 
 
(b) (‘ch_or_noch’). Voxel t was assigned to a different class before and after 
treatment (D(p,q) is high) with however a small change in membership degree 
(C(p,q) is low). The fact that C(p,q) is low suggests that pixel t may be close 
to the frontier between classes. Consequently the class ‘change’ may just be 
due to chance and the uncertainty is high. 
 
(c) (‘ch’). Voxel t was assigned to a different class before and after treatment 
(D(p,q) is high). Because the membership degree change was high (C(p,q) is 
high), voxel t cannot be close to the frontier between classes at least in one 
image. Consequently, the class change is not likely to be due to chance. The 
confidence is therefore high that the voxel changed. 
 
(d) (‘ch_and_noch’). Voxel t was assigned to the same class before and after 
treatment (D(p,q) is low) with however a high change in the membership 
degree (C(p,q) is high), which might be considered paradoxical, and might 





 The final step of the process is the definition of the voxel by 
voxel response status using the PET follow-up scans  and  
in combination with the computed ‘change map’ (section 
II.B.3). The voxels were here classified according to four 
different statuses: responders, stable or progressive for the 
tumoral voxels, and those belonging to the background (or 
physiological) in both scans. On the one hand, the voxels 
identified as ‘no change’ in the change map could belong 
either to the background or to the tumor in both images. 
Thanks to the background and tumor means 	  computed in 
the mapping step, the ‘no-change’ voxels were classified as 
either background or tumor. This classification was achieved 
by the computation of a mean square error (MSE) between the 
voxel’s value and the respective mean values of background 
and tumor in the pre treatment scan. Voxels classified as 
tumors and ‘no change’ are therefore designated as ‘stable’ 
(green voxels in the fusion map) On the other hand, the voxels 
identified as changing could be progressive (background 
evolving to tumor, red voxels in the fusion map) or responding 
(tumor evolving to background, blue voxels in the fusion map) 
and they were classified depending on the relative SUV 
variation between scans (decrease for responding, increase for 
progressive).  It is then possible to deduce individual 
segmented maps from the fusion map for the pre and post-
treatment scans. The segmentation map on the pre-treatment is 
deduced by the combination of voxels of the fusion map 
classified as responding and stable, whereas for the 
segmentation map on the post-treatment scan progressive and 
stable voxels are combined. SUVmean and MATV are then 
extracted by copying these delineations onto each scan. The 
overall tumor response is then deduced from the measured 
∆SUV and ∆MATV. 
C. Validation 
The validation of the change detection method has been 
carried out on both simulated and clinical datasets. 
 
1) Simulated datasets 
 
The considered simulations were realistic MATVs designed 
based on real head and neck and esophageal lesions observed 
in clinical datasets, to generate realistic shapes and activity 
distributions as well as locations in the body. The simulated 
dataset used in our work was generated according to a 
procedure previously described using the Monte Carlo 
simulations toolbox GATE (Geant4 Application for 
Tomography Emission) [34]. This procedure combines a 
numerical phantom describing thorax (NCAT) [34] or head 
and neck (Zubal) [34] anatomical regions and a model of 
tumors manually created from real clinical images. Phantoms 
and tumors are both defined as Non-uniform rational B-
splines. The voxelized phantom associated with attenuation 
coefficients and activity labels is then combined with a highly 
detailed model of the Philips Allegro PET scanner previously 
validated [35], and simulated in GATE in order to generate 
PET listmode data that is then reconstructed as 3D simulated 
images with voxel size 4×4×4 mm3 (same as the clinical 
images), for which the ground-truth is known in the simulated 
phantoms (see examples in figure 4). 
Each case contains two follow-up 3D PET scans, one pre 
and one post treatment. The original clinical cases used to 
design the simulated cases were classified as partial 
responders or progressive disease after radio-chemotherapy. 
In this study, 25 simulated follow-up cases were considered, 
with various MATV shapes and tumor-to-background contrast 
ratios. Half of the simulated datasets, representing 13 out of 25 
cases, were generated from patients’ classified as partial 
responders. The 12 other cases were designed based on 
patients classified as progressive disease. 
In order to assess the robustness of our method, three noise 
levels were considered for each case, by selecting 100, 80 and 
60% of the simulated lines of response for the iterative 
reconstruction respectively. Consequently, 75 simulated 
follow-up cases were generated. Similarly to the observed 
clinical datasets, both homogenous and heterogeneous tracer 
uptake distributions within the MATV were simulated. The 
current implementation of our approach does not however 
allow finer characterization of the evolution of radiotracer 
uptake heterogeneities within the MATV since it does not 
explicitly model heterogeneity parameters, although 
depending on the delineations and appearance of pre and post 
treatment scans, such variations might still be highlighted in 
the generated maps. Consequently, in all simulated scans the 
voxels were assumed to belong either to the background (BD) 
or to the tumor (MATV). The table 2 provides the mean tumor 
volume and tumor-to-background ratios simulated for pre and 
post treatment scans. 
 
TABLE II 
  Tumour volume (cm3) T/B ratio 
PET 1 27.5 ± 19 (3.8 - 90) 5.3 ± 2 (2.7 - 9.8) 
PET 2 26.3 ± 23 (1.9 - 100.9) 4.4 ± 1.7 (2.0 - 8) 
Mean tumor to background ratios and mean tumor volumes computed for all 
the simulated follow-up cases. 
 
 
2)  Evaluation metrics for simulated datasets 
 
For simulated datasets, the ground-truth (GT) is available. 
The assessment of the change detection method was achieved 
by computing relative volume errors (VE) and classification 
errors (CE) for each simulated tumor, as well as the errors in 
estimating the volume change. CE are defined as the sum of 
positive and negative classification errors (background voxels 
classified as tumor or tumor voxels classified as background 
respectively) [23]. As illustrated in the figure 4, for each 
simulated case, segmented maps of the pre and post treatment 
scans were obtained with the adaptive threshold (see section 
II.C.5) and the change detection method. VE and CE were 
larger than 100% in some cases for which adaptive threshold 






3) Clinical datasets 
 
The proposed method was also applied to real clinical 
datasets. Seven patients with esophageal or head and neck 
cancer undergoing concomitant radiochemotheray between 
2005 and 2008 were considered. Two 18F-FDG PET scans 
were acquired on a PET/CT Philips Gemini scanner following 
standard clinical protocol before and after treatment. Images 
were reconstructed with voxel size 4×4×4 mm3 (same as the 
simulated dataset). Four patients were classified as partial 
responders according to the RECIST criteria, one month after 
the completion of the therapy. The three others patients were 
classified as complete responders. According to the recent 
PERCIST recommendations including PET measurements, a 
response may be characterized by a SUV relative decrease 
above 30%, with no volume increase or apparition of new 
lesions [18]. This 30% value has been chosen because of the 
reproducibility of SUV measurements which has been 
determined to be within this ±30% range. This reproducibility 
range was evaluated on double baseline (also called "test-
retest") PET images, which consisted in repeated imaging of 
the patients at a few days interval without treatment in 
between. It has been recently demonstrated that using the 
FLAB method to delineate MATVs led to similar 
reproducibility performance of about ±30% [14]. The authors 
therefore concluded that future PERCIST guidelines should 
consider MATV variations larger than 30% to characterize 
response or progression. Visual illustrations of two clinical 
cases are provided in the figure 6.  
 
4) Quantitative variation for clinical datasets 
 
Contrary to the simulated validation, no ground-truths were 
available for the clinical follow-up cases. Therefore, the 
evaluation of the methods was performed by comparing the 
measured variation of several quantitative indices with respect 
to the known response to therapy of the patients. This response 
was evaluated 1 month after the completion of the 
concomitant radio-chemotherapy using conventional thoraco-
abdominal CT and endoscopy. Patients were classified as non 
responders (NR) including stable and progressive disease, 
partial responders (PR) or complete responders (CR). 
Response evaluation was based on CT evolution between pre-
treatment and post-treatment scans using RECIST (Response 
Evaluation Criteria in Solid Tumours). Patients also 
underwent fibroscopy in case of partial or complete response. 
Complete response was confirmed by the absence of visible 
disease in the endoscopy and no viable tumor on biopsy. 
Partial CT response was confirmed by macroscopic residual 
(>10% viable) on biopsy. No discordance was observed 
between pathological and CT evaluation. The variation of the 
MATV (MATV) and mean SUV (SUVmean) between the 
pre-treatment and post-treatment PET scans were computed 
for both approaches using delineations on both scans deduced 
from the fusion maps (see figure 1 and section II.B.4) or 
directly obtained with the adaptive thresholding used by two 
different clinicians (see section II.C.5). These measurements 
were compared to the variation of maximum SUV (SUVmax) 
with or without PVE correction. In order to measure the 
SUVmean variations for complete responders patients, the VOI 
defined in the first follow-up scan were automatically copied 




5) Alternative approaches used for comparison 
 
In both simulated and clinical datasets, the change detection 
method was compared to semi-automated approaches that 
have been proposed for patient monitoring studies. Only the 
SUVmax variation is currently considered in clinical routine to 
characterize response. In order to take into account the mean 
SUV and MATV variations, adaptive threshold-based methods 
were used and applied to each scan independently. Several 
studies have demonstrated that the fixed threshold methods 
were not accurate and robust enough [36] [37] and were 
therefore not considered here. The adaptive threshold method 
takes into account the background uptake and the applied 
threshold value is computed from the estimated contrast 
between the tumor activity and the background activity, and 
selected based on previously carried out optimization for a 
given scanner using phantom acquisitions of spheres [36].  
However, the use of adaptive thresholding requires the 
manual placement of a ROI in the background for an 
estimation of its uptake. For the simulated datasets, the 
background uptake was simulated as homogeneous and the 
background value was automatically determined. Only one 
result for the adaptive thresholding is therefore provided for 
simulated datasets. On the other hand, clinical datasets often 
exhibit much more heterogeneous physiological background 
uptake, especially in the mediastinum and head and neck 
regions. The manual placement of the background region of 
interest may therefore lead to significant inter observer 
variability as previously demonstrated [38]. In our study, two 
nuclear medicine physicians with similar training and 
experience manually placed the background ROI on each PET 
scans of the clinical datasets, therefore leading to two different 
results denoted tb1 and tb2 in the tables and figures. They 
followed a specific protocol as they were instructed to place 
the ROI at least a few cm away from the lesions. They were 
however free to choose the actual size, shape and placement of 
the ROI. 
III. RESULTS 
A. Results on simulated datasets 
 
Illustrations of fusion maps obtained by applying the change 
detection method on simulated data are provided for two cases 
in figure 4 (e). For an easier interpretation of the maps, color 
codes have been associated with each type of response. Blue 
areas depict the responding tumor voxels. Voxels appearing in 
both scans (stable voxels) are characterized in green. Tumor 
voxels representing progressive disease are red. In both 
illustrated cases classified as partial responders, only green 
and blue areas appear. On each map, the voxel intensity is 
automatically set as the SUV relative variation (SUV) 




case, no significant differences were observed on the 
segmentation of the pre and post treatment scans for both 
approaches. The second case illustrates a heterogeneous 
uptake in the tumor of the pre treatment scan. The lesion 
partially responded to the treatment and exhibited a 
homogenous uptake in the second scan. The obtained 
segmentations of the MATV in the post treatment scan are 
similar for both approaches. By contrast, the adaptive method 
clearly underestimated the MATV in the pre-treatment scan, 
contrary to the change detection method. 
Case 1 
   
  


















(f) (g) (h) (i) 
 
 
Fig 4: Illustration of two simulated cases (only one central 2D slice of the 3D 
volume is shown), with (a) the simulated pre treatment PET scan and (b) its 
binary ground-truth, (c) the simulated post treatment PET scan and (d) its 
binary ground-truth. (e) is the fusion map obtained with the proposed method. 
(f) and (g) are individual delineations on pre and post treatment PET scans 
respectively, obtained with the adaptive threshold. (h) and (i) are individual 
delineations obtained on the pre and post treatment PET scans respectively, by 
selecting voxels using the fusion map (e): for the pre treatment scan, tumor 
volume is obtained using responding (blue) and stable (green) voxels of the 
fusion map (e) whereas for the post treatment scan, tumor volume is obtained 
using stable and progressive (red) voxels. In this example there are no 
progressive voxels. 
 
Figure 5 provides the VE and CE obtained by the adaptive 
threshold and change detection methods. The threshold-based 
method was applied independently on each scan. For both 
approaches, VE1 and VE2, CE1 and CE2 are the volume and 
classifications errors respectively assessed for the pre-
treatment and post treatment scans. For both scans, the VE and 
CE associated to the threshold method (VE1: -25±20%, VE2: -
24±29%, CE1: 27±16%, CE2: 26±25%) were significantly 
(p<0.01) higher than the ones associated with the use of the 
change detection approach (VE1: +2±26%, VE2: -2±31%, CE1: 
17±6%, CE2: 19±7%). Standard deviations of VE for the 
proposed method were higher than the adaptive thresholding 
(26% vs. 20% and 31% vs. 29%) although the difference was 
not significant (p>0.05), whereas the standard deviations of 
CE were significantly (p<0.001) smaller (6% and 7% vs. 16% 
and 25%). Adaptive threshold led to a systematic under 
estimation in most of the cases, with some errors above 100%, 
whereas the change detection approach led to a mix of over 
and under evaluations of the true volumes (as demonstrated by 
the low mean VE and associated standard deviations), with no 
absolute errors (either VE or CE) above 30%. In these 
simulated cases, both homogenous and heterogeneous uptakes 
were simulated in the MATV according to the observed 
clinical scan. The adaptive threshold consistently failed to 
delineate heterogeneous ones, contrary to our change detection 
approach that prove much more robust in such configurations. 
Both methods provided similar errors in estimating the MATV 
evolution between the two scans (23±45% for change 





Fig 5: Mean and standard deviation for (a) VE and (b) CE, for the pre (EV1, 
EC1) and post (EV2, EC2) treatment scans, for adaptive threshold (tb) and 




























The impact of the registration error has been measured for a 
sub-group of the simulated data, by shifting the second follow-
up scan from one and two voxels in a random direction. For 
one voxel shift (7 mm), volume errors of the first and the 
second follow-up scan increased to +11.4±21% and 
+5.3±12%. By contrast, a shift of two voxels (14mm) led to 
significantly (p<0.01) higher VE for both follow-up scans, 
respectively +27.5±28% and +19.6±26%. 
B. Results on clinical datasets 
 
The results obtained on clinical datasets are illustrated in 
figure 6 for two patients, with the same set of color and voxels 
intensities as described in the simulated images validation.  
The quantitative measurements for each patient are provided 
in table 3. According to the response status, mean 
measurements were computed and presented in table 4 and 5 
for the patients classified as complete and partial responders 
respectively. Contrary to the simulated datasets, the clinical 
images have a noisier and more heterogeneous background 
making the change detection more challenging. 
TABLE III 






































Tb 1 -39 -83 
-36 -49 Tb 2 -51 -55 
Change -57 -34 
5 
Tb 1 -30 -62 
-26 -36 Tb 2 
 
-35 -47 
Change -38 -33 
6 
Tb 1 -27 -38 
-33 -41 Tb 2 -34 -5 








Measurements of MATV, SUVmean and SUVmax evolution, computed with the 
adaptive threshold and the change detection methods for each patients. 
 
The patients 1 to 3 were classified as complete responders to 
the therapy. Therefore, the volume variation was set at V=-
100%. Only the variation of SUVmean computed for both 
methodologies were compared with the SUVmax with or 
without PVE correction. For all the CR cases, the SUVmean 
were close (-74±10% for T1, -73±11% for T2 and -64±14% for 
the change detection method). These measures are close to 
those obtained with the SUVmax (-56±14% without the PVC 
and -66±20% with PVC). As expected, PVC led to a higher 
variation (and associated standard deviation) of the SUVmax. 
TABLE IV 














20.3 Tb 2 -72.7 ± 11.1 -100 
Change -64.2 ± 13.7 -100 
Mean measurements of MATV, SUVmean and SUVmax evolution for patients 
classified complete responders, computed with the adaptive threshold and the 
change detection methods for all the patients. 
 
Regarding patients 4 to 7 classified as partial responders 
(PR), the lesions were expected to exhibit a significant 
decrease in activity and volume between the first and the 
second follow-up scan. In the recent PERCIST criteria, PR is 
characterized by a SUVpeak decrease higher than 30%. 
Moreover, a decrease of the MATV is also expected between 
the follow-up scans. Considered as the gold standard in the 
clinical routine, the SUVmax variation was assessed as higher 
than -30% (-39±16% without PVC and -48±14% with PVC). 
These measurements are similar to the SUVmean variations 
computed with both approaches. No significant differences 
were observed in the mean variation of SUVmean with both 
clinicians (-39±14% for T1, -46±14% for T2), which are 
slightly lower than the measurements computed with the 
change detection method (-49±18%). On the contrary, the 
variations of MATV were found to be significantly different 
between both clinicians (-67±22% for T1, -44±27% for T2, 
p<0.01) as well as with the change detection method (-36±8%) 
(p<0.001). The standard deviations associated with the 
adaptive threshold method (22 and 27%) were significantly 
(p<0.001) higher than the one estimated with the change 
detection method (8%). 
 
TABLE V 





















Change -49.1 ± 17.7 
-36.6 ± 
7.5 
Mean measurements of MATV, SUVmean and SUVmax evolution for patients 
classified partial responders, computed with the adaptive threshold and the 
change detection methods for all the patients. 
 
In order to illustrate the respective behaviors of the adaptive 
threshold and change detection methods, two clinical follow-
up cases corresponding to patients 4 and 6 are provided in the 
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Fig 6: Illustration of the results for the clinical cases of patients 4 and 6, with 
(a) and (b) the pre and post treatment PET images respectively, (c) the 
classification map, (d-e) and (f-g) individual segmented maps for pre and post 
treatment obtained with the adaptive thresholding for the two clinicians, and 
(h-i) the segmentations obtained through the change detection method. 
For patient 4, whereas the variation of SUVmean are close for 
T1 and T2 (-39% and -51% respectively), the MATV variations 
are much more different (-83% and -55% respectively). The 
measurements obtained with the change detection method are 
in line with the PR status of the patient (SUVmean=-57%, 
MATV= -28%). The measurements obtained for the patient 6 
illustrate the poor reproducibility of the adaptive threshold 
method. Whereas the segmentations obtained for the post 
treatment scan are similar for both clinicians, the 
segmentations obtained for the first pre-treatment differ. These 
results can be explained by the heterogeneous distribution of 
tracer uptake within the background of the mediastinum 
combined with the fact that each clinician placed the 
background region of interest in a different position, leading to 
large differences in the estimation of this background uptake 
used by the adaptive threshold to compute a solution. This is 
consistent with previous observations in esophageal cancer 
[38], whereas in lung cancer the difference was not significant 
due to more homogeneous uptake of FDG in the lungs [39]. 
This led to high differences between MATV measured by the 
two clinicians (-38% for T1, -5% for T2). SUVmean variation 
however, were quite close (-27% for T1, -34% for T2). By 
contrast to the adaptive method, the change detection approach 
succeeded in identifying both MATVs, as it can be seen in the 
segmented maps. Hence, the quantitative variation of SUV 
and volume measured with the change detection approach are 
coherent with the partial response (SUVmean=-31%, 
MATV=-37%). 
For all PR patients, SUVmean and MATV decrease obtained 
with the change detection approach were below -30%, 
whereas several results obtained using the adaptive threshold 
were not (-30% SUVmean for patient 5 (Tb 1), -25% SUVmean 
for patient 6 using (Tb 1) and -5% MATV (Tb 2). 
IV. DISCUSSION 
In clinical oncology, one application of PET imaging is the 
assessment of early response to therapy by analyzing 
sequential scans during treatment [5-7]. Up to now, most of 
proposed studies characterizing the therapeutic response have 
been based on the measurement of the variation of a single 
quantitative parameter, usually the maximum SUV. 
The proposed method is aimed at assessing the response 
using follow-up PET scans, through a change detection 
approach. The method is divided in subsequent steps of 
individual images mapping, change signature of global and 
local parameters and change detection using the Dezert-
Smarandache (DSm) theory (see figure 1). Allowing the 
combination of multiple sources of information and modeling 
the uncertainty or conflict between these sources, the change 
detection with DSm theory applied on follow-up scans was 
expected to produce more reliable results than independent 
segmentations performed on each scan separately. However, 
the method requires accurate rigid registration of both images, 
which can limit the applicability of the approach to body 
regions and types of lesions less impacted by such issues. To 
reliably apply the method in more complex cases, clinical 
acquisitions protocols would require additional standardization 
to minimize changes, and respiratory motion as well as 
potential additional corrections would be required on each 
image before applying this approach. The last step of the 
change detection method consists in classifying the local 
evolution of the MATV using recently proposed criteria [18]. 
The change detection method was applied on both simulated 
and clinical follow-up datasets, and compared with adaptive 
threshold-based delineations performed separately on each 
scan. With simulated datasets, the ground-truths associated to 
each scan allowed the computation of volume and 
classifications errors. 25 follow-up cases, composed of two 
scans acquired before and during the treatment, were 
simulated with various tumor-to-background ratios, tumor 
shapes, levels of noise and with homogeneous or 
heterogeneous tracer activity within the MATV. In both pre 
and post treatment scans, the VE and CE associated with the 
adaptive threshold method were significantly higher than those 
measured with the change detection method. These high errors 
obtained with adaptive threshold can be explained by its 
inability to accurately take into account heterogeneous 
distributions of radiotracer within the MATV. The change 








uptake within the tumor. Although CE associated with the 
proposed method were measured around 20%, this 
performance needs to be assessed within the context of the 
size of the tumors relatively to the voxel size (4×4×4 mm3), 
especially for post treatment lesions that have shrunk. 
Although both methods provided similar accuracy in 
estimating the volume evolution between two scans 
(~25±45%), a correct volume evolution can be also reached by 
two incorrect delineations in the two scans. In several cases 
concerning the adaptive thresholding approach, complete 
failures with errors >100% were obtained but were limited to 
100% to avoid excessive bias. Classification errors were 
significantly lower for both pre- and post-treatment with the 
proposed approach. This has to be considered since the goal of 
the proposed method is not only to provide an estimation of 
the volume evolution between the two scans (the only metric 
that could be used in the case of clinical datasets), but also to 
provide more accurate delineations in both pre- and post-
treatment images, as well as a quantitative fusion map 
describing voxel-by-voxel evolutions with color coding. 
In clinical datasets, the adaptive threshold and change 
detection methods were compared with the variation of 
maximum SUV in the follow-up images. The SUVmean 
measurements were also computed for both methods. Finally, 
in order to more accurately characterize the response, MATV 
variations were computed for each approach. 
For patients classified as complete responders, similar 
measurements were observed between SUVmax and SUVmean 
variations estimated with the adaptive threshold and the 
change detection method. Regarding the four patients 
classified as partial responders, there were no significant 
differences between the variation of SUVmax and SUVmean 
assessed by both approaches. By contrast, the MATV 
variations were significantly different for the adaptive method 
results obtained by the two clinicians and the developed 
approach. The MATV variations measured with the change 
detection approach were less variable and more consistent 
with the status of partial response. It also led to visually more 
satisfying delineations than adaptive threshold that prove more 
sensitive to noise and uptake heterogeneities in both MATV 
and background. 
In this study, only the evolution of the tumor volume as a 
whole was characterized, although since the changes are 
characterized voxel by voxel, local changes in intra-tumor 
activity can be highlighted by the current implementation of 
the method, and may for instance highlight appearance of 
necrosis or disappearance of high uptake regions within the 
lesions. In further developments, the finer characterization of 
the evolution of tracer uptake heterogeneity within the MATV 
will be considered. The use of textural features analysis to 
characterize tracer uptake heterogeneity within MATV in PET 
images [40] could provide a certain number of additional 
features characterizing local and regional changes and could 
be combined with those already implemented in the use of the 
DSm theory presented here, especially regarding the 
combination of several sources of information, for example by 
considering two sizes of the estimation cube (3×3×3 and 
5×5×5 for example), or additional textural features analysis. 
V. CONCLUSION 
A novel method based on the change detection principle has 
been proposed to estimate a local response to therapy in 
oncology. Using the recent paradoxical theory, modeling the 
conflict and imprecision between the fused sources, the 
change detection approach aims at detecting the tumor 
evolutions more accurately than independent segmentations 
performed on each PET image separately. In this study the 
proposed method was validated on realistic simulated images 
and applied to clinical datasets. It was compared favorably to 
threshold-based method applied separately on each follow-up 
scans. In the simulated validation, the adaptive threshold 
approach led in both pre and post treatment images to higher 
errors than the change detection method. Regarding the 
clinical datasets, whereas no difference was observed in the 
case of patients classified as complete responders, the adaptive 
threshold was much less resilient to the noise and tracer 
uptake heterogeneity than our proposed method in the case of 
partial responders. For these cases, the proposed approach led 
to measurements more consistent with the response status of 
the patients. Further work will consist in applying the change 
detection method on more extensive clinical datasets in the 
context of therapy assessment in oncology, although some 
limitations of the applicability of the methods have been 
identified for lesions in areas more impacted by respiratory 
motion or other inter-scans registration issues. Moreover, the 
method will be extended to explicitly model tracer uptake 
heterogeneity evolution using textural features 
characterization and quantification. 
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